Gabbay E - Search Results

1

Review of bosentan in the management of pulmonary arterial hypertension.

Gabbay E, Fraser J, McNeil K. Gabbay E, et al. Vasc Health Risk Manag. 2007;3(6):887-900. Vasc Health Risk Manag. 2007. PMID: 18200808 Free PMC article. Review.

2

Quality of life in pulmonary arterial hypertension: improvement and maintenance with bosentan.

Keogh AM, McNeil KD, Wlodarczyk J, Gabbay E, Williams TJ. Keogh AM, et al. Among authors: gabbay e. J Heart Lung Transplant. 2007 Feb;26(2):181-7. doi: 10.1016/j.healun.2006.11.009. J Heart Lung Transplant. 2007. PMID: 17258153 Clinical Trial.

3

Bosentan therapy in patients with pulmonary arterial hypertension: the relationship between improvements in 6 minute walk distance and quality of life.

Strange G, Keogh AM, Williams TJ, Wlodarczyk J, McNeil KD, Gabbay E. Strange G, et al. Among authors: gabbay e. Respirology. 2008 Sep;13(5):674-82. doi: 10.1111/j.1440-1843.2008.01326.x. Respirology. 2008. PMID: 18713089

4

Pulmonary arterial hypertension: a new era in management.

Keogh AM, McNeil KD, Williams T, Gabbay E, Cleland LG. Keogh AM, et al. Among authors: gabbay e. Med J Aust. 2003 Jun 2;178(11):564-7. doi: 10.5694/j.1326-5377.2003.tb05360.x. Med J Aust. 2003. PMID: 12765505 Review.

5

The Bosentan Patient Registry: long-term survival in pulmonary arterial hypertension.

Keogh A, Strange G, McNeil K, Williams TJ, Gabbay E, Proudman S, Weintraub RG, Wlodarczyk J, Dalton B. Keogh A, et al. Among authors: gabbay e. Intern Med J. 2011 Mar;41(3):227-34. doi: 10.1111/j.1445-5994.2009.02139.x. Intern Med J. 2011. PMID: 20002851

6

Design and delivery of an e-learning curriculum for physicians involved in the management of pulmonary hypertension.

Dalton B, McNeil K, Keogh A, Williams T, Proudman S, Gabbay E, Kotlyar E, Weintraub R, Kermeen F, Celermajer D, Boland J. Dalton B, et al. Among authors: gabbay e. Int J Clin Pract. 2012 Nov;66(11):1117-24. doi: 10.1111/j.1742-1241.2012.02997.x. Int J Clin Pract. 2012. PMID: 23067036

7

Pulmonary hypertension in pregnancy: two cases and review of the literature.

Higton AM, Whale C, Musk M, Gabbay E. Higton AM, et al. Among authors: gabbay e. Intern Med J. 2009 Nov;39(11):766-70. doi: 10.1111/j.1445-5994.2009.02051.x. Intern Med J. 2009. PMID: 19912403 Review.

8

Assessment and treatment of pulmonary arterial hypertension: an Australian perspective in 2006.

Gabbay E, Reed A, Williams TJ. Gabbay E, et al. Intern Med J. 2007 Jan;37(1):38-48. doi: 10.1111/j.1445-5994.2006.01242.x. Intern Med J. 2007. PMID: 17199843 Review.

9

Pharmacoeconomic evidence of bosentan for pulmonary arterial hypertension.

Strange G, Keogh A, Dalton B, Gabbay E. Strange G, et al. Among authors: gabbay e. Expert Rev Pharmacoecon Outcomes Res. 2011 Jun;11(3):253-63. doi: 10.1586/erp.11.26. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 21671693 Review.

10

Implications of exercise-induced pulmonary arterial hypertension.

Fowler RM, Maiorana AJ, Jenkins SC, Gain KR, O'Driscoll G, Gabbay E. Fowler RM, et al. Among authors: gabbay e. Med Sci Sports Exerc. 2011 Jun;43(6):983-9. doi: 10.1249/MSS.0b013e318204cdac. Med Sci Sports Exerc. 2011. PMID: 21085040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters